Skip to main content
FRNM
NASDAQ Life Sciences

Freenome Swings to $60M Profit on $183.5M Q3 Revenue After FDA Nod

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Industrial
Sentiment info
Positive
Importance info
8
Price
$10.69
Mkt Cap
$1.157B
52W Low
$9.71
52W High
$17.5
52W Position info
10% above low
Off High info
39% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

FRNM is trading near its 52-week low of $9.71 (10% above the low).

Summary

Freenome's first quarter as a public company produced $183.5 million in revenue versus $1.0 million a year ago, almost all of it the $180.0 million recognized under its collaboration and license agreement after FDA approval of SimpleScreen CRC. GAAP net income was $60.1 million against a $64.5 million loss in Q3 2025, and adjusted EBITDA came in at $117.9 million. The company ended September with $430.0 million in cash and marketable securities and generated $38.4 million of operating cash flow. Full-year 2026 revenue guidance of $192 million to $194 million implies a modest fourth quarter, since nine-month revenue was already $190.0 million. Abbott launched SimpleScreen CRC in the U.S. on September 30, and Freenome expects its next two single-cancer data readouts in December, with the first asymptomatic multi-cancer readout in mid-2027.

At the time of this announcement, FRNM was trading at $10.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $9.71 to $17.50. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

FRNM - Latest Insights

FRNM
Oct 20, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $12.13
Real-time Price: $11.50 info
Change: -$0.630 (-5%) info
Market Cap: $1.242B info
FRNM
Aug 18, 2026, 4:51 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $13.45
Real-time Price: $11.50 info
Change: -$1.95 (-14%) info
Market Cap: $1.242B info
FRNM
Aug 13, 2026, 5:28 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $11.61
Real-time Price: $11.50 info
Change: -$0.110 (-0.95%) info
Market Cap: $1.242B info
FRNM
Aug 12, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $12.29
Real-time Price: $11.50 info
Change: -$0.790 (-6%) info
Market Cap: $1.242B info
FRNM
Jul 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $12.21
Real-time Price: $11.50 info
Change: -$0.710 (-6%) info
Market Cap: $1.242B info